Basal Cell Carcinoma Treatment Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: B12B94A2A072EN
Market Monitor Global

Abstracts

Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC.

Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo).

This report contains market size and forecasts of Basal Cell Carcinoma Treatment in Global, including the following market information:

Global Basal Cell Carcinoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Basal Cell Carcinoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Basal Cell Carcinoma Treatment include Roche, Sun Pharmaceuticals, Bausch Health Companies, Taro Pharmaceuticals and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Basal Cell Carcinoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Basal Cell Carcinoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, by Type, 2021 (%)

• Topical Treatment
• Hedgehog Pathway Inhibitor Therapy
• Mohs Surgery
• Other Surgeries
• Other Treatments

Global Basal Cell Carcinoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Others

Global Basal Cell Carcinoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Basal Cell Carcinoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Basal Cell Carcinoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Sun Pharmaceuticals
• Bausch Health Companies
• Taro Pharmaceuticals
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Basal Cell Carcinoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Basal Cell Carcinoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BASAL CELL CARCINOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Basal Cell Carcinoma Treatment Market Size: 2021 VS 2028
2.2 Global Basal Cell Carcinoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Basal Cell Carcinoma Treatment Players in Global Market
3.2 Top Global Basal Cell Carcinoma Treatment Companies Ranked by Revenue
3.3 Global Basal Cell Carcinoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Basal Cell Carcinoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Basal Cell Carcinoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Basal Cell Carcinoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Basal Cell Carcinoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Basal Cell Carcinoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Basal Cell Carcinoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Topical Treatment
  4.1.3 Hedgehog Pathway Inhibitor Therapy
  4.1.4 Mohs Surgery
  4.1.5 Other Surgeries
  4.1.6 Other Treatments
4.2 By Type - Global Basal Cell Carcinoma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Basal Cell Carcinoma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Basal Cell Carcinoma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Basal Cell Carcinoma Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Basal Cell Carcinoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Basal Cell Carcinoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Basal Cell Carcinoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Basal Cell Carcinoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Basal Cell Carcinoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Basal Cell Carcinoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Basal Cell Carcinoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Basal Cell Carcinoma Treatment Revenue, 2017-2028
  6.3.2 US Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.3.3 Canada Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Basal Cell Carcinoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Basal Cell Carcinoma Treatment Revenue, 2017-2028
  6.4.2 Germany Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.3 France Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.5 Italy Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.6 Russia Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Basal Cell Carcinoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Basal Cell Carcinoma Treatment Revenue, 2017-2028
  6.5.2 China Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.3 Japan Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.6 India Basal Cell Carcinoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Basal Cell Carcinoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Basal Cell Carcinoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Basal Cell Carcinoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.3 Israel Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Basal Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.5 UAE Basal Cell Carcinoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Basal Cell Carcinoma Treatment Major Product Offerings
  7.1.4 Roche Basal Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Sun Pharmaceuticals
  7.2.1 Sun Pharmaceuticals Corporate Summary
  7.2.2 Sun Pharmaceuticals Business Overview
  7.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Major Product Offerings
  7.2.4 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 Sun Pharmaceuticals Key News
7.3 Bausch Health Companies
  7.3.1 Bausch Health Companies Corporate Summary
  7.3.2 Bausch Health Companies Business Overview
  7.3.3 Bausch Health Companies Basal Cell Carcinoma Treatment Major Product Offerings
  7.3.4 Bausch Health Companies Basal Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bausch Health Companies Key News
7.4 Taro Pharmaceuticals
  7.4.1 Taro Pharmaceuticals Corporate Summary
  7.4.2 Taro Pharmaceuticals Business Overview
  7.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Major Product Offerings
  7.4.4 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Taro Pharmaceuticals Key News
7.5 Mylan
  7.5.1 Mylan Corporate Summary
  7.5.2 Mylan Business Overview
  7.5.3 Mylan Basal Cell Carcinoma Treatment Major Product Offerings
  7.5.4 Mylan Basal Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Mylan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Basal Cell Carcinoma Treatment Market Opportunities & Trends in Global Market
Table 2. Basal Cell Carcinoma Treatment Market Drivers in Global Market
Table 3. Basal Cell Carcinoma Treatment Market Restraints in Global Market
Table 4. Key Players of Basal Cell Carcinoma Treatment in Global Market
Table 5. Top Basal Cell Carcinoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Basal Cell Carcinoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Basal Cell Carcinoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Basal Cell Carcinoma Treatment Product Type
Table 9. List of Global Tier 1 Basal Cell Carcinoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Basal Cell Carcinoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Basal Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Basal Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Basal Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Basal Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Basal Cell Carcinoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Basal Cell Carcinoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Basal Cell Carcinoma Treatment Product Offerings
Table 32. Roche Basal Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Sun Pharmaceuticals Corporate Summary
Table 34. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Product Offerings
Table 35. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Companies Corporate Summary
Table 37. Bausch Health Companies Basal Cell Carcinoma Treatment Product Offerings
Table 38. Bausch Health Companies Basal Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Taro Pharmaceuticals Corporate Summary
Table 40. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Product Offerings
Table 41. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Mylan Corporate Summary
Table 43. Mylan Basal Cell Carcinoma Treatment Product Offerings
Table 44. Mylan Basal Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Basal Cell Carcinoma Treatment Segment by Type in 2021
Figure 2. Basal Cell Carcinoma Treatment Segment by Application in 2021
Figure 3. Global Basal Cell Carcinoma Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Basal Cell Carcinoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Basal Cell Carcinoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Basal Cell Carcinoma Treatment Revenue in 2021
Figure 8. By Type - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Basal Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Basal Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Basal Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Companies Basal Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mylan Basal Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)